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Background: Between 25% and 40% of hospital admissions in elderly patients may be linked to drug-
related problems. Therefore prevention and recognition of inappropriate prescribing of medicines in
elderly patients is one of the principle health care quality and safety issues.
Aim: To identify and compare the rate of inappropriate prescribing in elderly patients using two validated
screening tools: STOPP/START criteria and Beers criteria.
Materials and methods: A cross-sectional observational study on prescriptions of 600 patients aged 65
years was conducted. STOPP/START criteria and Beers criteria were applied to detect inappropriate
prescriptions. Feedback was obtained from clinicians about measures to reduce potentially inappropriate
prescriptions (PIPs) and related adverse drug events.
Results: There were 19.8% and 7.3% PIPs found using STOPP/START criteria and Beers criteria, respectively.
The most commonly found PIP with both criteria was the prescribing of calcium channel blockers among
hypertensive patients with chronic constipation. Of the 19.8% PIPs found with STOPP/START criteria, 7%
were potential prescribing omissions, the most common of which was statins not prescribed for diabetic
patients with multiple cardiovascular risk factors. STOPP/START criteria detected more of PIPs in in-
patients than outpatients. Polypharmacy and increasing age were important risk factors for PIPs. Most of
the clinicians agreed that monitoring of adverse drug reactions would be helpful.
Conclusion: The STOPP/START criteria detected more PIPs compared with the commonly used Beers
criteria. Application of such screening tools to prescribing decisions may reduce unnecessary medication,
related adverse events, hospital admissions, and cost.
Copyright  2013, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC.
 
Open access under CC BY-NC-ND license.1. Introduction
Inappropriate medication use is highly prevalent among elderly
patients (age  65 years). Certain drugs are considered potentially
inappropriate in old age because of the higher risk of intolerance
related to adverse pharmacodynamics or pharmacokinetics or
drugedisease interactions.1 Between 25% and 40% of hospital ad-
missions in elderly patients may be linked to drug-related prob-
lems. These observations have formed the basis for various sets ofAnandnagar, Sinhgad Road,
Y.S. Karandikar), sidharthrc@
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.A. Pandit).
IBM Road, Kondhwa 411 048,
linical Gerontology & Geriatrics. Pcriteria for potentially inappropriate prescription (PIP) in older
people. The most frequently cited explicit indicator is the Beers
criteria.2
Beers criteria were developed in the USA, ﬁrst published in 1991
and subsequently modiﬁed in 1997 and in 2003.3 Modiﬁed Beers
criteria consists of two lists of drugs to be avoided in elderly pa-
tients: independent of diagnosis and considering diagnosis. Few
studies mention that these criteria has some serious ﬂaws such as
not taking into account all of the factors that deﬁne high quality
healthcare for the individual, and do not address the burden of
comorbid disease and patients’ preferences and have little evidence
of validity and reliability. They do not detect omission of drugs etc.,
and are not sufﬁciently sensitive for the detection of serious
adverse drug events that contribute to hospitalization in older
people.4 For these reasons, new geriatric PIPs criteria have been
devised and validated. For the detection of potential errors of
prescribing commission and omission, new screening tools of olderublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Table 1
Baseline characteristics of the study population.
Total no. of prescriptions Inpatients Outpatients
n ¼ 600 n ¼ 300 n ¼ 300
Age group
65e74 y 485 (80.83) 222 (74) 263 (87.66)
75e84 y 98 (16.33) 63 (21) 35 (11.66)
85 y 17 (28.33) 15 (5) 2 (0.66)
Sex
Male 370 (61.66) 194 (64.66) 176 (58.66)
Female 230 (38.33) 106 (35.33) 124 (41.33)
Number of drugs per prescription
<5 264 (44) 27 (9) 237 (79)
5e9 246 (41) 195 (65) 51 (17)
 10 90 (15) 78 (26) 12 (4)
Morbidity pattern
Cardiovascular disorders 162 (27) 75 (25) 87 (29)
Endocrinal disorders 105 (17.5) 63 (21) 42 (14)
Respiratory disorders 81 (13.5) 42 (14) 39 (13)
Miscellaneous 81 (13.5) 30 (10) 51 (17)
Fall/fracture 66 (11) 30 (10) 36 (12)
Gastrointestinal disorders 54 (9) 30 (10) 24 (8)
Neurological disorders 51 (8.5) 30 (10) 21 (7)
Data are presented as n (%).
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to right treatment (START) are being used.
STOPP comprises 65 indicators that pertain primarily to
important drugedrug and drugedisease interactions potentially
leading to side effects such as cognitive decline and falls, and
therapeutic duplication. START incorporates 22 evidence-based
indicators of common prescribing omissions.5
The literature related to the use of PIPs from India is scarce.
Mostly, Beers criteria have been applied in Indian geriatric pa-
tients.6,7 Hence, this study was undertaken at a tertiary care
teaching hospital with the aim of evaluating the performance of
STOPP/START and Beers criteria in terms of identifying PIPs in the
elderly.
The primary objectives of the present studywere to identify PIPs
in elderly patients and to compare the performance of STOPP/START
criteria to that of Beers criteria as screening tools for inappropriate
prescribing in elderly patients. Secondary objectives were to study
the morbidity and drug use pattern in the elderly, to appraise cli-
nicians and get their feedback about ways of avoiding PIPs, and to
study the association of various patient attributes with PIPs.
2. Materials and methods
2.1. Study population
The study was started after receiving approval from the Insti-
tutional Ethics Committee (BVDU/MC/14/2011). This cross-
sectional observational study was conducted at a tertiary care
hospital on prescriptions of 600 elderly patients ( 65 years) from
May 2011 to December 2011. Patients in both inpatient department
(IPD) and outpatient department (OPD) settings who gave
informed consent for viewing their prescriptions were included in
the study. Patients with incomplete information regarding their
clinical data were excluded from the study.
2.2. Data collection
Patient demographic characteristics, chief complaints, diag-
nosis, signiﬁcant history of other diseases, previous medication,
etc., and detailed information about prescribed drugs were ob-
tained from case ﬁles and prescriptions. Data were noted in the
World Health Organization (WHO) encounter form and prescribing
indicator form. These indicator forms have been formulated by
WHO for the uniform assessment of basic facets of drug use across
nations after a conference in Nairobi on the rational use of drugs.8
Numbers of drugs per prescription, drugs prescribed by generic
name, and drugs listed in the essential drug list were calculated.
2.3. Application of screening tool
Prescribed drugs were then analyzed using Beers criteria4 and
STOPP/START criteria.5 Drugs prescribed among the study popula-
tion were compared with the drugs included in the Beers and
STOPP/START criteria. Drug prescribing was deemed inappropriate
if the prescribed drug(s) were included in the listed criteria.
2.4. Feedback from clinicians
Inappropriate medications were reported to the clinicians who
were asked to ﬁll out a feedback form containing measures to
reduce inappropriate prescriptions in the elderly. Measures sug-
gested to improve prescribing in elderly were: monitoring of
adverse drug reactions, therapeutic drug monitoring, referring to
screening tools, performing speciﬁc laboratory tests, avoiding
concurrent use of drugs, drug dose adjustments in elderly patients,and considering drugedrug interactions when prescribing more
than one drug.
2.5. Statistical analysis
Data were entered into Microsoft Excel and analyzed using
GraphPad Prism software version 5 (GraphPad Software, Inc. La
Jolla, CA 92037, USA). Rate of inappropriate prescribing measured
using the two criteria was compared using z-test of proportions for
the both care settings (i.e., IPD and OPD) and overall study cohort.
In addition, using unadjusted logistic regression we assessed the
factors associated with inappropriate prescribing criteria. Odds
ratio was generated using a logistic regression to provide data on a
prescription being inappropriate or not [increased (if > 1) or
decreased (if < 1)].
3. Observations and results
Prescription data were collected from 300 IPD and 300 OPD
patients for analysis.
3.1. Demographic characteristics
As shown in Table 1, 74% patients were aged 65e74 years.
Sex-wise distribution showed that hospitalized male patients
received more prescriptions. The mean number of medicines pre-
scribed per patient for 300 inpatients was 8.18 for 3.2 items for the
300 outpatients. Themost commonly used drugs were atorvastatin,
aspirin, amlodipine, proton pump inhibitors, paracetamol, and B
complex. Table 1 also shows the distribution of major systems
involved in the disorders found in these elderly people. The most
commonly affected systems were cardiovascular (27%), endocrine
(18%), and respiratory (14%).
3.2. Inappropriate prescriptions
A total of 12.9% PIPs and 7% potentially prescribing omissions
(PPOs) were found using STOPP/START criteria. The most common
PIPs according to STOPP were the prescribing of calcium channel
blockers (CCBs) for hypertensive patients with chronic constipation
and nonsteroidal anti-inﬂammatory drugs (NSAIDs) given to
Table 2
Detection of inappropriate prescriptions using STOPP/START criteria.
IPD OPD
I. Potentially inappropriate prescriptionsdaccording
to STOPP
Cardiovascular system
CCB in chronic constipation 7 1
Aspirin with no history of coronary/cerebral
/peripheral arterial symptoms/occlusive event
2
Aspirin, clopidogrel with concurrent bleeding
disorders
1
Loop diuretic for dependent ankle edema 1
Clopidogrel with concurrent bleeding disorder 1
Aspirin at dose > 150 mg/day 4 1
Gastrointestinal system
Loperamide for unknown cause of diarrhea 3
Respiratory system
Systemic corticosteroids instead of inhaled
corticosteroids in COPD
4 1
Theophylline as monotherapy for COPD 2
Musculoskeletal system
Nonsteroidal anti-inﬂammatory drugs with
moderate hypertension
8
Urogenital system
Antimuscarinic with urinary retention 1
Endocrine system
b-blockers with diabetes mellitus and episode
of hypoglycemia
6 1
Prone to falls
Vasodilators 3 1
Opioids 5 1
First generation antihistamines 2 2
Benzodiazepines 1
Analgesic drugs
Opioids with constipation
Duplication of drug classes 18 7
Total 60 17
II. Potentially inappropriate omissiondaccording
to START
Cardiovascular system
Statin therapy with a documented history of
coronary, cerebral risk factors
11 2
Aspirin or clopidogrel with a documented
history of atherosclerotic coronary, cerebral,
or peripheral vascular disease in patients with
sinus rhythm
6 2
Warfarin in the presence of chronic atrial
ﬁbrillation
1
Angiotensin-converting enzyme inhibitor
with congestive heart failure
2
Endocrine system
Metformin with type-2 diabetes þ/e metabolic
syndrome
2 3
Statins therapy in DM if one or more co-existing
major cardiovascular risk factor present
9 2
Total 33 9
Grand Total 93 (31) 26 (8.6)
Data are presented as n (%).
CCB ¼ calcium channel blockers; COPD ¼ chronic obstructive pulmonary disease;
START ¼ screening tool to alert to right treatment; STOPP ¼ screening tools of older
persons’ prescriptions.
Table 3
Detection of inappropriate prescriptions using Beers criteria.
Name of drug Severity IPD OPD
Independent of diagnosis
Alprazolam High 1
Chlorzoxazone High 2 6
Hydroxyzine High 1
Anticholinergic and antihistaminic High 10
Amitriptyline High 2
Propoxyphene Low 2
Dependent of diagnosis
CCB with constipation Low 7
Benzodiazepine and history of fall High 4
Antimuscarinic with bladder outﬂow
obstruction
High 5
Chronic constipation with
anticholinergic
Low 1
Chlordiazepoxide with COPD High 1
NSAID High 1 1
Total 21 (7) 23 (7.6)
Data are presented as n (%).
CCB ¼ calcium channel blocker; COPD ¼ chronic obstructive pulmonary disease;
IPD ¼ inpatient department; NSAID ¼ nonsteroidal anti-inﬂammatory drug;
OPD ¼ outpatient department.
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were prescribed to patients with hypertension and diabetes.
Finally, there were duplicate drugs prescriptions among 4.1% of
patients. Common PPOs identiﬁed included statin not given for
elderly patients with diabetes mellitus (DM) with cardiovascular
disease. Similarly, antiplatelet agent(s) were not prescribed among
diabetic hypertensive patients (Table 2).
Beers criteria detected 7.3% of PIPs. The most common PIPs
found using Beers criteria were CCB given for hypertensive patients
with chronic constipation, use of antihistamines in the elderly, andchlorzoxazone and short-acting benzodiazepine prescribed to an
elderly patient with a history of falls (Table 3).
3.3. Predictors of PIPs
Based on the STOPP/START criteria, the likelihood of inappro-
priate prescriptions was higher among patients in the 75e84 years
age group (odds ratio, 3.16) and among patients receiving 10
drugs in both criteria (odds ratios, 11.33 and 1.70, respectively), as
shown in Table 4.
3.4. Comparison between STOPP/START and Beers criteria
The subgroup analysis (Table 5) showed that when both criteria
are applied to the prescriptions, there is no statistically signiﬁcant
difference in rate of PIP detection based on the two criteria in an
OPD setting. However, the rate of PIP detection varied signiﬁcantly
between the two criteria in the IPD setting with STOPP/START
criteria being able to detect more PIPs than Beers criteria
(p < 0.0001, z ¼ 7.49). STOPP/START criteria are overall (IPD þ OPD)
superior to Beers criteria (p < 0.0001, z ¼ 6.18).
3.5. Feedback from clinicians
As shown in Table 6, monitoring adverse drug reactions, ther-
apeutic drug monitoring, and use of screening tools were the
measures most commonly agreed upon by clinicians to avoid
inappropriate prescriptions in elderly patients.
4. Discussion
Patients whose prescriptions were studied were aged 65e85
years. The majority belonged to the subgroup of 65e74 years,
whereas studies conducted in other countries were comprised
mainly of patients aged >75 years.9,10 This observation may be
related to lower life expectancy in developing countries such as
India.
The study also revealed a typical morbidity pattern in India of
which the most common cardiovascular disorder was hyperten-
sion. 6,7 Fifty percent of hypertensive patients in our study also
suffered from type-2 DM. Comorbid hypertension and DM were
Table 4
Predictors of potentially inappropriate prescriptions (PIPs).
Variable Total Patients with PIPs
by STOPP/START
Odds ratio 95% conﬁdence
interval
Patients with
PIPs by Beers
Odds ratio 95% conﬁdence
interval
All 600 119 (19.9) 44 (7.3)
Age
65e74 y 485 (80.8) 78 (16.08) 1 30 (6e18) 1
75e84 y 98 (16.3) 37 (37.7) 3.16*** 1.968e5.089 14 (14.28) 2.528*** 1.286e4.969
 85 y 17 (28.3) 4 (23.52) 1.606 0.5100e5.054 0 0.4267 0.02504e7.271
Sex
Male 370 (61.7) 84 (22.7) 1 26 (7e02) 1
Female 230 (38.3) 35 (15.2) 0.61* 0.3958e0.9436 18 (7.82) 1.123 0.6013e2.099
Drug distribution
<5 264 (44) 16 (6.06) 1 20 (7.57) 1
5e9 246 (41) 65 (26.42) 5.566*** 3.117e9.939 13 (5.28) 0.6807 0.3309e1.400
 10 90 (15) 38 (42.22) 11.33*** 5.876e21.83 11 (12.22) 1.699 0.7799e3.700
Data are presented as n (%) unless otherwise indicated.
***p < 0.0001; **p < 0.001, *p < 0.01.
START ¼ screening tool to alert to right treatment; STOPP ¼ screening tools of older persons’ prescriptions.
Table 6
Feedback from clinicians (n ¼ 50).
Serial no. Suggestions Accept
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pitalizations among our study population.
In this study, we found that only 4.7% of drugs were prescribed
by generic name. WHO results show that 60% percent of drugs are
prescribed as generic.8 Patients are usually prescribed expensive
brand drugs and, given the fact that old people receive a greater
number of drugs, this would have adverse economic consequences.
The essential drug list publicized by WHO and the government
of India was considered the standard for determining essential
drugs.11,12 According to WHO, the percentage of drugs on the
essential drug list is 70e90%. In our study 67.17% drugs were listed
on the essential drug list, a percentage similar to the WHO result.
Inappropriate prescription (IP) is an important health care issue
in elderly patients that deserves attention. In many studies it was
shown that polypharmacy and increasing age were important risk
factors for IP.2,13 We got similar results using STOPP/START criteria
(Table 4) where the most common inappropriate prescriptions
were found in the age group >75 years and in patients receiving
multiple (10) drug prescriptions.
Compared with previous reports in India, the incidence of PIP in
our study was similar when applying Beers criteria.7,14 Incidence of
PIP, however, was signiﬁcantly higher (19.8%) when STOPP/START
criteria were used. To the best of our knowledge this is the ﬁrst
study evaluating IP using STOPP/START criteria in India. Hence, we
have compared our results using STOPP/START criteria with those
from some other countries to clarify the scenario in our setup.
Prevalence studies in European and other countries show sub-
stantial rates of prescription of PIP (22e77%) and a similarly high
prevalence rate of PPO in hospitals as well (41e66%).4,9,15 The
prevalence of PIP among elderly patients in India was very high but
still lower than in Europe in spite of the fact that more drugs are
prescribed per prescription.7,10,13 This may be due to the differences
between treatment guidelines in Europe and India.
Nineteen instances of PIP and 21 cases of PPO listed in STOPP/
START criteria are not mentioned in Beers’ criteria,4,5 which includeTable 5
Comparison of the performance of STOPP to that of Beers’ criteria.
Number of potentially inappropriate prescriptions
STOPP Beers z Two-tailed p
Total 119 (19.8) 44 (7.3) 6.18 <0.0001
IPD 93 (31) 21 (7) 7.49 <0.0001
OPD 26 (8.6) 23 (7.6) 0.46 0.6419
Data are presented as n (%) unless otherwise indicated.
IPD ¼ inpatient department; OPD ¼ outpatient department; STOPP ¼ screening
tools of older persons’ prescriptions.omission of drugs PPO, excessive duration and dose of proton pump
inhibitors, b-blockers with DM and episode of hypoglycemia,
loperamide for unknown cause of diarrhea, systemic corticoste-
roids instead of inhaled corticosteroids in chronic obstructive pul-
monary disease, use of opioids, benzodiazepines, ﬁrst generation
antihistamines and vasodilators in patients with history of falling,
and duplicate drug class prescriptions. All of these add unneces-
sarily to the cost and complexity of drug regimens for older people
without providing additional therapeutic beneﬁt. Twenty-one in-
stances of these (PIP þ PPO) were identiﬁed in the present study.
CCBs prescribed to hypertensive patients with constipation
were the most commonly found IP using both criteria. One of the
adverse effects of CCBs is constipation due to smooth muscle
relaxation, and all old patients generally have decreased gastroin-
testinal motility so constipation becomes exaggerated, causing a
great discomfort to the patient. We found 15 patients complaining
of constipation being given CCBs. The prevalence of this parameter
in this study is higher than documented.9
The other PIP commonly found when using STOPP/START
criteria was b-blockers given to patients with DM and episodes of
hypoglycemia. Because nonselective b-blockers block lipolysis and
glycogenolysis (b2 mediated)-induce sympathetic stimulation, they
may interfere with recovery from hypoglycemia and mask tachy-
cardia or other warning signals of hypoglycemia.16 Even though
selective b-blockers are used, patients are frail elderly people with
limited physiological reserve, reduced homoeostasis, and dysre-
gulation of the immune system, all of which inﬂuence drug
handling and response. Hence, b-blockers should not be used in
diabetic patients when other alternatives exist. This criterion is not
mentioned in Beers criteria.1 Monitoring of adverse drug reactions should
be done
35 (70)
2 Therapeutic drug monitoring should be done 33 (66)
3 Such screening tools should be referred to while
prescribing drugs
30 (60)
4 Speciﬁc laboratory test should be done 27 (54)
5 Additional information required; information
provided is insufﬁcient for making clinical decisions
19 (38)
6 Concurrent use of drugs should be avoided 10 (20)
7 Drugedrug interaction should be considered when
prescribing more than one drug
9 (18)
8 Consider dose adjustment of drug in elderly patients 3 (6)
Data are presented as n (%).
Table 7
Characteristics of clinicians.
Department Professor Associate Professor Assistant Professor
Medicine 4 5 4
Ortho 2 2 2
Gynecology 2 3 3
Surgery 2 2 3
Opthalmology 2 2 1
ENT 1 1 2
Skin 1 1 2
Psychiatry 1 1 1
Total 15 17 18
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tadine, promethazine, and dexchlorpheniramine are antihistaminic
drugs with anticholinergic properties and are commonly pre-
scribed in outpatients. First generation antihistamines can cause
sedation and confusion along with anticholinergic side effects that
are troublesome in the elderly, such as dryness the of mouth,
blurred vision, constipation, and urinary retention.17 Such antihis-
tamines given to the elderly are inappropriate according to Beers
criteria (independent of diagnosis list). By contrast, STOPP/START
criteria highlight clinical conditions such as bladder obstruction,
glaucoma, dementia, etc. where it is potentially inappropriate to
prescribe any antihistamine with anticholinergic properties. This
allows freedom to prescribe antihistamines with anticholinergic
properties in situations where it may be indicated. This approach is
more ﬂexible than that of Beers criteria.
Similarly, STOPP/STARTcriteria detail particular instances where
prescription of NSAIDs is potentially inappropriate, e.g., with peptic
ulcer disease, heart failure, hypertension, prolonged treatment in
osteoarthritis or gout. These drugs given to hypertensive patients
(moderate: 160/100e179/109 mmHg; severe:  180/110 mmHg)
can exacerbate blood pressure or heart failure. This may be due to
its action on renal (auto regulatory) mechanisms that cause ﬂuid
retention and tolerance to antihypertensive drugs.18 They also in-
crease the risk of gastrointestinal hemorrhage and nephrotoxicity.2
One has to consider the riskebeneﬁt ratio when prescribing NSAIDs
to such patients. STOPP identiﬁed more admissions related to
adverse effects of NSAIDs than Beers criteria.
Falls with a resultant injury were among the most common
reasons for hospital admission in this study. Even though falls are
clearly multifactorial in nature, medication review is an essential
component of comprehensive falls assessment. STOPP/START
criteria identiﬁed 15 patients with a history of falls receiving IP
consisting of drugs such as antihistamines, opioids, benzodiaze-
pines, and vasodilator medications. Beers criteria identiﬁed
considerably fewer such patients (n ¼ 4) in whom risk was
increased as a result of IP. In both criteria, use of benzodiazepines is
considered inappropriate. The elderly have increased sensitivity to
benzodiazepines and metabolize long-acting sedative agents more
slowly.19,20 In general, all benzodiazepines increase the risk of
cognitive impairment, delirium, falls, fractures, and motor vehicle
accidents in such patients.
Prescribing duplicate drugs in the same prescription is inap-
propriate according to STOPP/START criteria, but this is not listed in
Beers criteria. We found 25 cases of drug duplication, which in-
cludes prescribing two drugs for the same purpose: pantoprazole
and ranitidine, metoclopramide and ondansetron; two different
brands of the same drug: alprazolam (Alprax and Restyl) and In-
jection Vitamin B12. This suggests negligence and ignorance when
writing prescriptions.
Screening with START criteria reveals the rate of underutiliza-
tion of medications for common conditions. Determination of PPO
is one of the important aspects of STOPP/START criteria but not of
Beers criteria. In this study, we found that PPO of statin and aspirin
for older diabetic patients with multiple CVD risk patients in India
was higher than that in Europe.7 This may be associated with
inadequate awareness of prescribing statins for these patients. In
India, the prescription of lipid-lowering drugs might be based on
the target levels of lipid proﬁle. Therefore, further investigation is
needed to clarify PPOs of statins and aspirin for diabetic patients
with multiple cardiovascular/cerebrovascular risks.
STOPP criteria detected a higher number of IPs in hospitalized
patients than Beers criteria in our study. Our results are similar to
the study done in Ireland.8 This may be due to various differences
between STOPP/ START criteria and Beers criteria summarized as
follows: (1) STOPP/START criteria contain more commoninappropriate prescriptions that are not mentioned in Beers
criteria; (2) STOPP/START criteria place special emphasis on po-
tential adverse drug interactions and duplicate drug class pre-
scriptions, (3) Beers criteria include several drugs that are no
longer available in India, (4) Beers criteria do not detect omission
of drugs as do START criteria, and (5) STOPP/START criteria are
organized according to the physiological system whereas Beers
criteria are not.
The higher number of IP detected by Beers criteria in OPD than
IPD is due to the fact that many patients were prescribed various
cough formulations containing ﬁrst generation antihistamines,
NSAIDs combined with muscle relaxants such as chlorzoxazone
and sedative agents such as alprazolam, zolpidem, and diazepam.
In STOPP/START CRITERIA these drugs are inappropriate only in
certain situations.
We reported the results of this study to clinicians who work in
various departments in our tertiary care hospital and have done
postgraduate studies in their respective ﬁelds (15 professors, 17
associate professors, and 18 assistant professors; Table 7). Fifty
(66.7%) out of 75 clinicians responded and their opinions are shown
in Table 6. When we reported the results of this study to clinicians,
90% of them were not aware of such screening tools. Clinicians
agreed that most of the inappropriate prescriptions were clinically
signiﬁcant and measures should be adopted to minimize them. The
results of this study reﬂect the need to update the clinicians on the
pharmacotherapy of elderly patients.
There are some limitations to this study.We did not follow up on
the patients studied so we were unable to ﬁnd any adverse drug
events. As these screening tools were developed in Europe and
America, prevalence of inappropriate prescriptions deﬁned by
these criteria may differ from that in India because of differences in
clinical practices and patient characteristics. This suggests the need
for the development of such validated screening tools in India
considering the clinical guidelines and population characteristics of
India.
This study was undertaken and completed prior to the publi-
cation of the updated AGS 2012 Beers criterion21 and thus addi-
tional research is required to assess the impact of the revised AGS
2012 Beers criterion in detecting PIPs. The authors plan to conduct a
follow-up study using the revised Beers criterion.
In conclusion, the high prevalence of IP and preventable adverse
drug events related to IP in older people is unacceptable, and rep-
resents a public health hazard likely to grow in tandemwith ageing
populations. Although clinical judgment is most important,
prescription-screening tools can be used to detect IPs. STOPP/START
criteria detect a signiﬁcantly greater number of PIPs in IPD than
OPD. These criteria also detect more PIPs compared with the
commonly used Beers criteria. Although clearly not a substitute for
clinical assessment and judgment, these criteria encourage clini-
cians to consider medications as a possible cause of certain symp-
toms in the elderly, thereby avoiding unnecessary and potentially
harmful prescribing cascades. The criteria will need regular
Y.S. Karandikar et al. / Journal of Clinical Gerontology & Geriatrics 4 (2013) 109e114114updating in line with emerging evidence. Whether STOPP/START
criteria used as an intervention can signiﬁcantly improve pre-
scribing appropriateness or reduce drug-related morbidity or
mortality remains to be seen.Acknowledgments
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